S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
Pay Attention To Microcap Oil-Dri Corporation 
Growing Pains Cut Into Casey’s General Stores, Inc Profits
The Short-Squeeze In Dave & Buster’s Is On
Scholz replaces Merkel as German chancellor, opening new era
$56K Alzheimer’s drug avoiding Biden’s cost curbs, for now
Semi Season Continues: 3 Chip Stocks to Buy Now
Supply Chain Issues Getting You Down? Give Stocks for the Holidays Instead. Here's How
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
Pay Attention To Microcap Oil-Dri Corporation 
Growing Pains Cut Into Casey’s General Stores, Inc Profits
The Short-Squeeze In Dave & Buster’s Is On
Scholz replaces Merkel as German chancellor, opening new era
$56K Alzheimer’s drug avoiding Biden’s cost curbs, for now
Semi Season Continues: 3 Chip Stocks to Buy Now
Supply Chain Issues Getting You Down? Give Stocks for the Holidays Instead. Here's How
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
Pay Attention To Microcap Oil-Dri Corporation 
Growing Pains Cut Into Casey’s General Stores, Inc Profits
The Short-Squeeze In Dave & Buster’s Is On
Scholz replaces Merkel as German chancellor, opening new era
$56K Alzheimer’s drug avoiding Biden’s cost curbs, for now
Semi Season Continues: 3 Chip Stocks to Buy Now
Supply Chain Issues Getting You Down? Give Stocks for the Holidays Instead. Here's How
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
Pay Attention To Microcap Oil-Dri Corporation 
Growing Pains Cut Into Casey’s General Stores, Inc Profits
The Short-Squeeze In Dave & Buster’s Is On
Scholz replaces Merkel as German chancellor, opening new era
$56K Alzheimer’s drug avoiding Biden’s cost curbs, for now
Semi Season Continues: 3 Chip Stocks to Buy Now
Supply Chain Issues Getting You Down? Give Stocks for the Holidays Instead. Here's How
NYSEAMERICAN:ZOM

Zomedica Insider Trades

$0.39
+0.01 (+2.65%)
(As of 12/8/2021 04:00 PM ET)
Add
Compare
Today's Range
$0.37
▼
$0.40
50-Day Range
N/A
52-Week Range
$0.15
▼
$2.91
Volume
13.76 million shs
Average Volume
70.03 million shs
Market Capitalization
$379.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.52

Zomedica (NYSEAMERICAN:ZOM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.99%

Number Of
Insiders Buying
(Last 12 Months)
1

Amount Of
Insider Buying
(Last 12 Months)
$112.50 K

Number Of
Insiders Selling
(Last 12 Months)
6

Amount Of
Insider Selling
(Last 12 Months)
$5.15 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get ZOM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Zomedica stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Zomedica (NYSEAMERICAN ZOM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2021Johnny D PowersDirectorBuy250,000$0.45$112,500.00  
6/30/2021Robert CohenCEOSell543,750$0.82$445,875.00543,750  
6/15/2021Johnny D. PowersDirectorSell125,000$0.93$116,250.001,375,000  
6/1/2021Robert CohenCEOSell3,193,750$0.81$2,586,937.502,000,000  
5/17/2021Johnny D. PowersDirectorSell125,000$0.78$97,500.001,375,000  
5/3/2021Ann Marie CotterCFOSell19,444$1.06$20,610.6411,111  
4/12/2021Ann Marie CotterCFOSell58,332$1.16$67,665.1233,332  
4/12/2021Johnny D PowersDirectorSell750,000$1.16$870,000.00725,000  
4/12/2021Stephanie MorleyCMOSell805,000$1.16$933,800.001,764,580  
2/3/2021Christopher Ross MacleodDirectorSell6,400$1.10$7,040.00  
7/7/2020Johnny D PowersDirectorBuy625,000$0.16$100,000.00625,000  
8/28/2018James LebarDirectorSell200,000$2.15$430,000.00  
6/11/2018Rodney James WilliamsDirectorSell1,000$1.92$1,920.00  
6/1/2018Rodney James WilliamsDirectorSell2,000$1.92$3,840.00  
5/24/2018Rodney James WilliamsDirectorSell2,000$1.94$3,880.00  
(Data available from 1/1/2013 forward)












Zomedica (NYSEAMERICAN:ZOM) Insider Trade Frequently Asked Questions

Who is on Zomedica's Insider Roster?

The list of insiders at Zomedica includes Ann Marie Cotter, Christopher Ross Macleod, Johnny D Powers, Robert Cohen, and Stephanie Morley.Learn more on ZOM's insiders

What percentage of Zomedica stock is owned by insiders?

1.99% of Zomedica stock is owned by insiders. Learn more on ZOM's insider holdings

Which Zomedica insiders have been buying company stock?

The following insider purchased Zomedica stock in the last 24 months: Johnny D Powers ($212,500.00).

How much insider buying is happening at Zomedica?

Insiders have purchased a total of 875,000 Zomedica shares in the last 24 months for a total of $212,500.00 bought.

Which Zomedica insiders have been selling company stock?

The following insiders have sold Zomedica stock in the last 24 months: Ann Marie Cotter ($88,275.76), Christopher Ross Macleod ($7,040.00), Johnny D Powers ($870,000.00), Robert Cohen ($3,032,812.50), and Stephanie Morley ($933,800.00).

How much insider selling is happening at Zomedica?

Insiders have sold a total of 5,626,676 Zomedica shares in the last 24 months for a total of $5,145,678.26 sold.

This page was last updated on 12/9/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.